Stockscreener 앱 받기
7.47
2.75%
0.20
Exagen Inc 주식(XGN)의 최신 뉴스
Exagen director Jorey Chernett buys $104,440 in XGN stock By Investing.com - Investing.com South Africa
Form 4 Exagen Inc: John Aballi (Director, President and CEO) For: 16 October By Investing.com - Investing.com South Africa
Form 4 Exagen Inc: Jorey Chernett (10% Owner) For: 19 October By Investing.com - Investing.com South Africa
Exagen director Jorey Chernett buys $104,440 in XGN stock - Investing.com
Exagen director Jorey Chernett buys $104,440 in XGN stock By Investing.com - Investing.com Nigeria
Form 4 Exagen Inc: Jorey Chernett (10% Owner) For: 19 October - Investing.com Canada
Form 4 Exagen Inc: John Aballi (Director, President and CEO) For: 16 October - Investing.com UK
Exagen Director Jorey Chernett Reports Initial Ownership of 2.6 Million Shares - Kalkine Media
Exagen : Initial Statement of Beneficial Ownership (Form 3) - www.marketscreener.com
XGN Looks 113.8% Overvalued on GF Value™ - GuruFocus
Have Insiders Sold Exagen Shares Recently? - simplywall.st
Have Insiders Sold Exagen Shares Recently? - simplywall.st
Tax-driven stock sale and ESPP buy for Exagen (XGN) CFO - Stock Titan
XGN | Exagen Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Exagen Inc. (XGN) Stock Price & News - Syfe
Exagen (XGN) director grant corrects prior option total - Stock Titan
Exagen (NASDAQ: XGN) grants director options at $4.31 strike - Stock Titan
Exagen (NASDAQ: XGN) grants Paul Kim 37,500 options at $4.31 - Stock Titan
Exagen Q2 2026 slides: record revenue, stock surges 36% By Investing.com - Investing.com Nigeria
Flputnam Investment Management Co. Takes $1.34 Million Position in Exagen Inc. $XGN - MarketBeat
GSA Capital Partners LLP Makes New Investment in Exagen Inc. $XGN - MarketBeat
XGN Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts SentimentEarnings Acceleration Picks - vinanet.vn
Exagen Stock Price Forecast. Should You Buy XGN? - StockInvest.us
XGN Q2 2026 Earnings: Narrower -$0.13 Loss Beats Estimates; Shares Slip 2.66%Retail Earnings Report - vinanet.vn
XGN Q2 2026 Earnings: Narrower-than-Expected Loss Surprises Positively, Yet Shares Slip 1.99%Management Tone Analysis - vinanet.vn
Exagen at Canaccord Genuity growth conference: turnaround gains pace - Investing.com
Metagenomi Therapeutics: Q2 Earnings Snapshot - AOL.com
Exagen Inc. (NASDAQ:XGN) Analysts Are Pretty Bullish On The Stock After Recent Results - webull.com
Agenus: Q2 Earnings Snapshot - aol.com
Exagen Inc. (XGN) Climbs 4.25% to $6.87, Holding Above Key SupportTPO Profile - dars.gov.et
Exagen (XGN) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Rise 4.25%Negative Surprise Momentum - vinanet.vn
Exzeo: Q2 Earnings Snapshot - AOL.com
Xenon Pharmaceuticals: Q2 Earnings Snapshot - AOL.com
Exagen Q2 2026 Earnings: Record Revenue and Reduced EBITDA Loss - sekbernews.id
Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN) - The Globe and Mail
Exagen (XGN) Stock Gets Fair Value Boost As Analysts Weigh Growth And Execution - Yahoo Finance
XGN Maintains Buy Rating -- Price Target Raised to $10.00 by TD Cowen - GuruFocus
XGN Reiterates by B. Riley Securities -- Price Target Raised to $12 - GuruFocus
Exagen Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:XGN) 2026-08-05 - Seeking Alpha
XGN Maintained by BTIG -- Price Target Raised to $9.00 - GuruFocus
Insiders At Exagen Sold US$680k Of Stock Potentially Indicating Weakness - Moomoo
B. Riley Adjusts Price Target on Exagen to $12 From $8, Maintains Buy Rating - marketscreener.com
BTIG Research Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock - MarketBeat
Exagen Inc (XGN) (Q2 2026) Earnings Call Highlights: Record Reve - GuruFocus
Exagen: The Path To Profitability Just Became More Credible (NASDAQ:XGN) - Seeking Alpha
Exagen revenue reaches record level in Q2 2026 as test volume and ASP climb, lifts full year outlook - Traders Union
Exagen Inc. Stock 12‑Month Price Target Raised to $8.71, Implies 86% Upside - TradingView
Exagen Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Exagen Inc (XGN) (Q2 2026) Earnings Call Highlights: Record Revenue and Path to Profitability - Yahoo Finance
Exagen Q2 Earnings Call Highlights - Yahoo Finance
0.38%
5.67%
자본화:
|
볼륨(24시간):